相关实验视频
Updated: Jan 7, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
代谢功能障碍相关的脂肪肝炎的组合疗法:挑战和机遇
Xiao-Dong Zhou1,2, Qiong-Yue Fan1,2, Christopher D Byrne3
1MAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
针对多种途径的组合疗法在治疗代谢功能障碍相关的脂肪肝炎 (MASH) 方面表现有前途. 这些策略旨在比单药治疗更有效地改善肝脏健康和代谢结果.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 代谢疾病 代谢疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 代谢功能障碍相关的脂肪肝炎 (MASH) 是一种复杂的肝病,与肥胖和胰岛素抵抗有关.
- 目前的单通道疗法在肝纤维化和代谢参数方面提供了有限的改善.
研究的目的:
- 审查MASH的多目标和组合疗法.
- 检查MASH组合治疗的机制性理由,临床证据和实施考虑因素.
主要方法:
- 对MASH组合疗法的当前文献的综述.
- 分析不同药物类别组合的机制性理由.
- 检查新出现的临床证据和安全概况.
主要成果:
- 组合疗法可以调节MASH中的多种致病过程.
- 肝脏导向和全身代谢剂组合显示出改善肝脏组织学和代谢概况的潜力.
- 战略性药物配对可能会提高安全性和耐受性.
结论:
- 多目标和组合疗法为MASH管理提供了一个有前途的策略.
- 这些方法旨在在肝脏和全身健康方面实现更全面,更持久的改善.
- 需要一个框架来优化个性化的MASH管理.
更多相关视频
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
相关概念视频
Chronic Pancreatitis II: Collaborative Care
Assessment:
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion